Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies

December 19, 2023

https://www.prnewswire.com/news-releases/trinity-capital-inc-provides-40-million-term-loan-to-taysha-gene-therapies-302018200.html

PHOENIX, Dec. 19, 2023 /PRNewswire/ — Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity”), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $40 million in term loans to Taysha Gene Therapies, Inc. (NASDAQ: TSHA) (“Taysha”), a clinical-stage gene therapy company, pursuant to a Loan and Security Agreement dated November 13, 2023, by and among Taysha, the lenders party thereto from time to time (the “Lenders”), and Trinity, as administrative agent and collateral agent for the Lenders.

Read more at prnewswire.com

Related news for (TRIN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.